ulcerative colitis tagged posts

University of Louisville researchers have discovered how a naturally occurring microbial compound may help protect the gut and support future treatment strategies for inflammatory bowel disease (IBD).

IBD, which includes conditions such as Crohn’s disease and ulcerative colitis, affects millions of people worldwide. The disease is characterized by chronic inflammation and damage to the intestinal lining. A healthy gut barrier helps keep harmful bacteria from leaking out of the intestines while allowing nutrients to enter the body. In people with IBD, that barrier becomes weakened, leading to inflammation, pain and long-term complications.

A research team led by Venkatakrishna Rao Jala, associate professor in the Department of Microbiology and Immunology and UofL’s Brown Cancer C...

A new study published in Nature Communications demonstrates that a consortium of bacteria designed to complement missing or underrepresented functions in the imbalanced microbiome of inflammatory bowel disease (IBD) patients, prevented and treated chronic immune-mediated colitis in humanized mouse models. The study’s senior author, Balfour Sartor, MD, Midget Distinguished Professor of Medicine, Microbiology and Immunology, Co-Director of the UNC Multidisciplinary IBD Center, said the results are encouraging for future use treating Crohn’s disease and ulcerative colitis patients.

“The idea with this treatment is to restore the normal function of the protective bacteria in the gut, targeting the source of IBD, instead of treating its symptoms with traditional...

Highlights •atRA deficiency in colon cancer is driven by microbiota-induced inflammation •Treatment with atRA reduces tumorigenesis by enhancing a CD8+ T cell response •The enhanced CD8+ T cell response is due to upregulation of MHCI on tumor cells •CD8+ T cell cytotoxicity in human colon cancer correlates with local atRA metabolism

Mice with the cancer have lower-than-normal levels of the metabolite in their gut. Furthermore, colorectal cancer patients whose intestinal tissues express high levels of a protein that degrades retinoic acid tend to fare more poorly than their peers. The research is the first to unravel a complicated dance between retinoic acid levels, immune-related inflammation and gut microorganisms...

The research may strengthen researchers’ abilities to better predict a child’s risk for associated autoimmune diseases. Autoimmune diseases, eg type 1 diabetes, Crohn’s disease and juvenile idiopathic arthritis, collectively affect 1 in 12 persons in the Western hemisphere. They represent a significant cause of chronic disability.

“The results from this study enable us to better understand the genetic component of these diseases and how they are genetically related to each other, thereby explaining why different autoimmune disorders often run in the same family,” said Hakon Hakonarson, M.D., Ph.D.

The research encompassed 9 pediatric-onset autoimmune diseases (pAIDs): type 1 diabetes, celiac disease, juvenile idiopathic arthritis, common variable immunodeficiency, systemic lupus eryth...